Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

CUSIP: 005111109

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class
Equity / Common Stock, par value $0.001 per share
Total 13F shares
15,930,046
Total 13F value
$22,142,780
Holder snapshot 6 visible 7 signals
Share change
-1,824,898
Put/Call ratio
68%
SEC-reported price per share
$1.39
Number of holders
59
Value change
-$3,508,681
Number of buys
23
Open additional details 1 more signal available
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,359,615

Security key

005111109

Report period

Q1 2022

Institutions

59

Top holders

10

AFIB full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 Acutus Medical, Inc. SEC filings Acutus Medical, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F 3/4/5 Lead comparable stake: 4.4% Showing 1-6 of 15 holder rows.

Quick read

DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 4.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Comparable ownership Top 5
DEERFIELD MANAGEMENT COMPANY, L.P. 4.4%
ORBIMED ADVISORS LLC 4.4%
Capital World Investors 2.7%
GOLDMAN SACHS GROUP INC 2.3%
BlackRock Finance, Inc. 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
4.4%
$9,031,000
2,648,386 shares
 — 31 Dec 2021
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director, 10%+ Owner
13F 3/4/5
4.4%
$9,031,000
2,648,386 shares
 — 31 Dec 2021
Capital World Investors
13F
Company
13F
2.7%
$5,456,000
1,600,000 shares
 — 31 Dec 2021
GOLDMAN SACHS GROUP INC
13F
Company
13F
2.3%
$4,746,000
1,391,906 shares
 — 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
2.1%
$4,389,000
1,287,161 shares
 — 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
1.7%
$3,527,000
1,034,176 shares
 — 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
15,930,046
Rows available
59
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
67
Q1 2022 holders
59
Holder diff
-8
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .